Previous close | 17.50 |
Open | N/A |
Bid | 0.00 |
Ask | 0.00 |
Strike | 58.00 |
Expiry date | 2024-05-31 |
Day's range | 17.50 - 17.50 |
Contract range | N/A |
Volume | |
Open interest | 1 |
WILMINGTON, Del., May 22, 2024--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4, 2024.
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
(Updated - May 21, 2024 11:56 AM EDT)